FDA and CDC lift recommended pause on Johnson & Johnson (Janssen) COVID-19 vaccine use following thorough safety review : press release : embargoed until: Friday, April 23, 2021, 7:00 p.m. ET

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html

FDA and CDC lift recommended pause on Johnson & Johnson (Janssen) COVID-19 vaccine use following thorough safety review : press release : embargoed until: Friday, April 23, 2021, 7:00 p.m. ET

April 23, 2021
By Centers for Disease Control and Prevention (U.S.) ...

[PDF-90.94 KB]

Details Supporting Files You May Also Like

Details:

Corporate Authors:

Centers for Disease Control and Prevention (U.S.) ; United States. Food And Drug Administration.

Centers for Disease Control and Prevention (U.S.) ; United States. Food And Drug Administration. Less -
Description:

Following a thorough safety review, including two meetings of the CDC’s Advisory Committee on Immunization Practices, the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Janssen (Johnson & Johnson) COVID-19 Vaccine in the U.S. should be lifted and use of the vaccine should resume.
Subjects:

[+]

Coronavirus Infections/prevention & Control COVID-19 Vaccines COVID-19/prevention & Control Vaccines, Synthetic Viral Vaccines
Document Type:

Press Release
Name as Subject:

Janssen COVID-19 vaccine
Place as Subject:

United States
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:8790461a4e36412864eb89081857b487c51cde8349279cacfcfe0df6ec36275a
Download URL:

https://stacks.cdc.gov/view/cdc/105457/cdc_105457_DS1.pdf
File Type:

fda-cdc-lift-vaccine-use.html

htm

More +